Synthetic Biologics (SYN) Tops Q1 EPS by 1c

Synthetic Biologics (NYSE: SYN) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c